| |
| |
|
| Insider
Information: |
Tubridy Karen L |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
117,432 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$125,133 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
117,432 |
|
|
| Total
Value |
$125,133 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -69.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Carisma Therapeutics Inc |
CARM |
Chief Development Offi... |
2016-06-27 |
32,753 |
2015-06-26 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2020-02-28 |
84,679 |
2017-02-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2020-02-28 |
4 |
S |
$8.70 |
$30,050 |
D/D |
(3,454) |
84,679 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
88,133 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2019-04-11 |
4 |
D |
$7.70 |
$46,778 |
D/D |
(6,075) |
55,324 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
61,399 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2018-12-12 |
4 |
D |
$8.94 |
$106,636 |
D/D |
(11,928) |
30,229 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
41,518 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Development Officer |
• – – |
2017-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,000 |
23,000 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
Chief Development Officer |
• – – |
2016-06-27 |
4 |
S |
$2.08 |
$9,094 |
D/D |
(4,372) |
32,753 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
Chief Development Officer |
• – – |
2015-12-28 |
4 |
S |
$2.85 |
$12,617 |
D/D |
(4,427) |
32,973 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
Chief Development Officer |
• – – |
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
37,400 |
37,400 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
